You can use this form to request an appointment.
Once received, we will check the form details and confirm appointment times with you.
We cannot guarantee an appointment without confirmation.
In a previous blog post, we explained that people with asthma often confuse their symptoms with those of hay fever. But there are two other conditions that are even more similar: asthma and chronic obstructive pulmonary disease (COPD).
The symptoms of asthma and COPD, which are both serious, long-term lung diseases, are very similar and they’re often treated with the same medicines.
At YourGP private medical practice in Edinburgh, we have the brand new Glaxo Smith Klein inhaler that can prevent and relieve the symptoms of the two conditions.
Symptoms of asthma are usually caused by a trigger and include:
COPD is an umbrella term for a collection of serious, long term lung diseases, including chronic bronchitis and emphysema. Symptoms include:
As well as having similar symptoms, comorbidities (diseases and conditions that you have in addition to the main disease) for asthma and COPD are also often similar. They include:
However, one of the main differences between COPD and asthma is the age that symptoms begin.
Most people are initially diagnosed with asthma in childhood, however COPD, especially emphysema, is often caused by smoking – and people don’t usually get diagnosed until they’re in their 40s.
At YourGP, we have a new inhaler from Glaxo Smith Klein which allows patients to only use their inhaler once in any 24-hour period.
The inhaler, Relvar Ellipta, is effective over 24 hours, but it’s essential to use the medicine at the same time each day as this will help to keep you free of symptoms throughout the day and night.
The recommended dose is one inhalation, once daily, at the same time each day – not only when you have breathing problems or other symptoms of COPD and asthma.
Relvar Ellipta shouldn’t be used to relieve a sudden attack of breathlessness or wheezing – if you get this sort of attack you must use a quick-acting inhaler.
Relvar Ellipta contains two active substances: fluticasone furoate and vilanterol.
Fluticasone furoate belongs to a group of medicines called corticosteroids, which reduce inflammation and help to prevent attacks of asthma and aggravation of COPD.
Vilanterol, meanwhile, belongs to a group of medicines called long acting bronchodilators. It relaxes the muscles of the small air passages in the lungs. This helps to open the airways and makes it easier for air to get in and out of the lungs.
When you take these two active substances together regularly, they help control your breathing difficulties more than either medicine alone.
If you are suffering from asthma or COPD and want to find out more about Relvar Ellipta, use our online booking form to book an appointment, email our reception team at firstname.lastname@example.org or call us on 0131 225 5656.
I was warmly greeted by staff with genuine smiles. The staff made me feel very comfortable and engaged me in conversation about several topics which made waiting pass very pleasantly. I noticed they were proactive in making each person who arrived feel welcome, including the courier.